Everence Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $243K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $203K | Sell |
|
|||||
|
2024
Q3 | $236K | Hold |
|
|||||
|
2024
Q2 | $228 | Hold |
|
|||||
|
2024
Q1 | $258 | Hold |
|
|||||
|
2023
Q4 | $219K | Hold |
|
|||||
|
2023
Q3 | $209 | Hold |
|
|||||
|
2023
Q2 | $251K | Hold |
|
|||||
|
2023
Q1 | $274 | Hold |
|
|||||
|
2022
Q4 | $270 | Hold |
|
|||||
|
2022
Q3 | $256K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $272K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $320K | Hold |
|
|||||
|
2021
Q1 | $272K | Hold |
|
|||||
|
2020
Q4 | $261K | Hold |
|
|||||
|
2020
Q3 | $216K | Hold |
|
|||||
|
2020
Q2 | $250K | Hold |
|
|||||
|
2020
Q1 | $187K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $232K | Hold |
|
|||||
|
2019
Q1 | $246K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $205K | Buy |
|